4978.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 14:15):

Stats
今日成交量	287 800
平均成交量	542 659
市值	12.43B
EPS	¥0 ( 2024-02-08 )
下一个收益日期	( ¥-3.62 ) 2024-05-10
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	-53.67
ATR14	¥0.240 (0.17%)

音量相关性

長: -0.20 (neutral)

短: 0.99 (very strong)

Signal:(50.778) Expect same movement, but be aware

ReproCELL Incorporated 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ReproCELL Incorporated 相关性 - 货币/商品

0.71
( moderate )

0.29
( neutral )

0.54
( weak )

0.25
( neutral )

-0.71
( moderate negative )

ReproCELL Incorporated 财务报表

Annual	2022
营收:	¥2.95B
毛利润:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
营收:	¥2.95B
毛利润:	¥1.14B (38.64 %)
EPS:	¥-3.62

FY	2022
营收:	¥2.23B
毛利润:	¥803.44M (35.96 %)
EPS:	¥-7.57

FY	2021
营收:	¥1.29B
毛利润:	¥482.70M (37.53 %)
EPS:	¥-11.38

Financial Reports:

No articles found.

ReproCELL Incorporated

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

实时更新： ReproCELL Incorporated [4978.T]

Upcoming Earnings Alert